Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Novo Nordisk Inc.
Target Audience
The intended audience for this activity is endocrinologists, family medicine physicians, internists, nurse practitioners, physician assistants, pharmacists and other health care professionals involved in the management of patients with overweight and obesity.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate a multidisciplinary approach to treating overweight and obesity that addresses comorbidities and includes patients’ perspectives and shared decision-making.
- Advise patients appropriately about the effective use of commercial diets, exercise, and technology-driven interventions that can assist them in weight loss.
- Select pharmacotherapy for weight management based on individual needs, as well as the latest clinical evidence on their safe and effective use.
Course Chair
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine
Northwestern Medicine
Chicago, IL
Faculty
Scott Kahan, MD, MPH, FTOS, DABOM
Director, National Center for Weight and Wellness
Johns Hopkins Bloomberg School of Public Health
Washington, DC
Donna H. Ryan, MD, FACP, FTOS
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA
Patient Advocate
Patricia Nece, JD
Chair of the Board of Directors
Obesity Action Coalition
Alexandria, VA
Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Anastasia B. Jenkins, PharmD, BCNSP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.
This program is acceptable for 2.0 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-21-021-H01-P, effective 9/30/2021. This is a knowledge-based activity and there is no fee to attend.
Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.
This activity is approved for 2.0 contact hour(s) of continuing education (which includes 0.67 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 21085148. This activity was planned in accordance with AANP Accreditation Standards and Policies.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hours credit for completing this program.
This enduring material is approved for 1 year from the date of original release, September 30, 2021, to September 29, 2022.
How to Participate in This Activity and Obtain CME Credit
To participate in this CE activity, you must read the objectives, answer the poll and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, CPE Statement of Credit, or Contact Hours Certificate.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.
Course Chair and Faculty report the following relationship(s)
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Consulting Fee: Novo Nordisk, Weight Watchers
Contracted Research: Epitomee
Scott Kahan, MD, MPH, FTOS, DABOM
Consulting Fee: Gelesis, Lilly, Pfizer, Vivus
Royalty: Johns Hopkins University Press; Lippincott, Williams & Wilkins; Wolters-Kluwer
Donna H. Ryan, MD, FACP, FTOS
Consulting Fee: Boehringer Ingelheim, Calibrate/Redesign Health, Epitomee, Gila Therapeutics, IFA Celtic, Janssen, Lilly, Novo Nordisk, Phenomix, Real Appeal, Roman, Sanofi, Wondr Health, YSOPIA Bioscience
Speakers Bureau: Novo Nordisk
Ownership Interest: Calibrate/ReDesign Health, Epitomee, Gila Therapeutics, Phenomix, Scientific Intake, Xeno Bioscience
Patient Advocate reports the following relationship(s)
Patricia Nece, JD
Consulting Fee: Novo Nordisk
Reviewers report the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Anastasia B. Jenkins, PharmD, BCNSP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com